Loading...
•
Dec 31, 2020
CVS Health Q4 2020 Earnings Report
Reported fourth quarter and full-year 2020 results and provided 2021 full year guidance.
Key Takeaways
CVS Health's Q4 2020 results reflected COVID-19 impacts and related investments. Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year. The company utilized its capabilities and community presence for COVID-19 testing and vaccine administration.
Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year.
Full year and fourth quarter GAAP diluted earnings per share from continuing operations of $5.47 and $0.75
Full year and fourth quarter Adjusted EPS of $7.50 and $1.30
Generated full year cash flow from operations of $15.9 billion
Revenue by Segment
Forward Guidance
The Company’s full year 2021 GAAP diluted EPS from continuing operations is projected to be in the range of $6.06 to $6.22, and full year 2021 Adjusted EPS is projected to be in the range of $7.39 to $7.55. The Company’s full year 2021 cash flow from operations is projected to be in the range of $12.0 billion to $12.5 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...